🔎 Trials Near Me

Home › Autism Spectrum Disorder › NCT04936009

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

RecruitingHealthy volunteers welcome

Noninvasive Brain Stimulation to Treat Core Social Deficits in Autism Spectrum Disorder

Who can join

Ages 18 to 40 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Individuals between the ages of 18 and 40 years old with typical development or with a diagnosis of autism spectrum disorder.
* Individuals able to participate in an EEG and eye-tracking experiment.

Exclusion Criteria:

* Participants reporting significant head trauma or serious brain illness.
* Participants with major psychiatric illness that would preclude completion of study measures.
* Participants with a history of serious medical illness, stroke, seizures, epileptiform EEG abnormalities, or family history of seizures.
* Participants taking prescription medications that may affect cognitive processes under study.
* Participants who have taken alcohol or recreational drugs within the preceding 24 hours.
* Females of known/suspected pregnancy or who test positive on a pregnancy test.
* Participants with a history of metalworking or injury by shrapnel or metallic objects are also excluded.
* Participants with a history of prior TMS therapy or use of an investigational drug within 12 weeks of visit.
* Participants with an IQ (intelligence quotient) below 80.

About the study

This is a randomized interventional study designed to evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS) on neural and behavioral facets of social cognition in adults with autism spectrum disorder (ASD).

What is being tested

Sponsor: Yale University · Participants: 60 · Started: Mar 17, 2022

Contact the study team

Official record on ClinicalTrials.gov — NCT04936009

Locations in the U.S.

ConnecticutYale University Child Study Center, New Haven

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.